Live Breaking News & Updates on Roger Belusa

Stay updated with breaking news from Roger belusa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cantargia appoints Dr. Dominique Tersago as Chief Medical Officer

LUND, Sweden, July 8, 2022 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced. ....

Liselotte Larsson , Prnewswire Cantargia , Exevir Bio , Peter Juul Madsen , Bristol Myers Squibb , Roger Belusa , Dominique Tersago , University Of Antwerp , Nasdaq Stockholm , Chief Medical Officer , Juul Madsen , Precision Promise ,

Cantargia AB: Cantargia appoints Dr. Dominique Tersago as Chief Medical Officer

LUND, Sweden, July 8, 2022 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced the strengthening of its management team through the appointment of Dr. Dominique ....

Liselotte Larsson , Prnewswire Cantargia , Exevir Bio , Peter Juul Madsen , Bristol Myers Squibb , Roger Belusa , Dominique Tersago , University Of Antwerp , Nasdaq Stockholm , Chief Medical Officer , Juul Madsen ,

Cantargia publishes interim report for first quarter 2022

Interim report for first quarter 2022 is now available on the company's web page. ....

European Patent Office , Systemic Sclerosis World Congress , European Atherosclerosis Society Congress , Pancreatic Cancer Action Network Pan , Pancreatic Cancer Action Network , Precision Promise , Systemic Sclerosis World , Roger Belusa , Interim Chief Medical Officer , European Atherosclerosis Society , Nasdaq Stockholm ,

Cantargia AB: Cantargia strengthens executive management in preparation for late-stage clinical development

STOCKHOLM, March 10, 2022 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced the strengthening of its medical team. Dr. Roger Belusa has been appointed interim ....

Prnewswire Cantargia , Ignacio Garcia Ribas , Roger Belusa , Karolinska Institute , Nasdaq Stockholm , Chief Medical Officer ,

Cantargia AB: Correction: Cantargia strengthens executive management in preparation for late-stage clinical development

STOCKHOLM, March 10, 2022 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced the strengthening of its medical team. Dr. Roger Belusa has been appointed interim Chief ....

Prnewswire Cantargia , Ignacio Garcia Ribas , Roger Belusa , Karolinska Institute , Nasdaq Stockholm , Chief Medical Officer ,